YASUSHI NAGATA

Last Updated :2022/12/02

Affiliations, Positions
Graduate School of Biomedical and Health Sciences(Medicine), Professor
Web Site
E-mail
nagathiroshima-u.ac.jp
Self-introduction
I was appointed as a first Director of Department of Radiation Therapy, Hiroshima University Hospital in January 2008. In April 2009, I was appointed as a first Professor of the Department of Radiation Oncology, Graduate School of Medicine, Hiroshima University. I was also nominated as a Director of the Hiroshima High- Precision Radiotherapy Cancer Center since October 2015.

Basic Information

Major Professional Backgrounds

  • 2012/04/01, 2019/03/31, Hiroshima University, Institute of Biomedical & Health Sciences, Professor
  • 2015/10/01, Hiroshima High-Precision Radiotherapy Cancer Center, Director

Academic Degrees

  • Doctor of Philosophy in Medical Science, Kyoto University

Educational Activity

  • [Bachelor Degree Program] School of Medicine : Program of Medicine : Medicine
  • [Master's Program] Graduate School of Biomedical and Health Sciences : Division of Integrated Health Sciences : Program of Medical Physicist
  • [Doctoral Program] Graduate School of Biomedical and Health Sciences : Division of Biomedical Sciences : Program of Medicine

Research Fields

  • Medicine,dentistry, and pharmacy;Clinical internal medicine;Radiation science

Educational Activity

Course in Charge

  1. 2022, Undergraduate Education, Year, Systemic Disease Control
  2. 2022, Undergraduate Education, Intensive, Practice for medical research
  3. 2022, Undergraduate Education, Intensive, Practice of Medicine I
  4. 2022, Undergraduate Education, Intensive, Practice of Medicine II
  5. 2022, Graduate Education (Doctoral Program) , 1Term, Principles of Oncology
  6. 2022, Graduate Education (Master's Program) , First Semester, Research on Radiation Oncology
  7. 2022, Graduate Education (Master's Program) , Second Semester, Research on Radiation Oncology
  8. 2022, Graduate Education (Master's Program) , First Semester, Physics of Diagnostic Radiology
  9. 2022, Graduate Education (Master's Program) , First Semester, Radiation Oncology Physics
  10. 2022, Graduate Education (Master's Program) , Second Semester, Physics of Nuclear Medicine
  11. 2022, Graduate Education (Master's Program) , First Semester, Radiation Oncology
  12. 2022, Graduate Education (Master's Program) , Second Semester, Seminar on Radiation Oncology Physics
  13. 2022, Graduate Education (Master's Program) , Second Semester, Seminar on Radiation Dosimetry
  14. 2022, Graduate Education (Master's Program) , Second Semester, Seminar on Physics of Diagnostic Imaging
  15. 2022, Graduate Education (Master's Program) , First Semester, Seminar on Physics of Nuclear Medicine
  16. 2022, Graduate Education (Master's Program) , First Semester, English for Scientific Paper
  17. 2022, Graduate Education (Master's Program) , First Semester, Biostatistics
  18. 2022, Graduate Education (Master's Program) , Second Semester, Health Physics
  19. 2022, Graduate Education (Doctoral Program) , 1Term, Principles of Oncology
  20. 2022, Graduate Education (Doctoral Program) , 1Term, Practice of Oncology
  21. 2022, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Radiation Oncology
  22. 2022, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Radiation Oncology
  23. 2022, Graduate Education (Doctoral Program) , First Semester, Advanced Research on Radiation Oncology
  24. 2022, Graduate Education (Doctoral Program) , Second Semester, Advanced Research on Radiation Oncology
  25. 2022, Graduate Education (Doctoral Program) , Second Semester, Advanced Research on Radiation Oncology
  26. 2022, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Radiation Oncology
  27. 2022, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Radiation Oncology
  28. 2022, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Radiation Oncology
  29. 2022, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Multidisciplinary Tumor Board
  30. 2022, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Multidisciplinary Tumor Board

Research Activities

Academic Papers

  1. Long-term outcomes of intraluminal brachytherapy in combination with external beam radiotherapy for superficial esophageal cancer., Long-term outcomes of intraluminal brachytherapy in combination with external beam radiotherapy for superficial esophageal cancer., 17(3), 2012
  2. Case reports of portal vein thrombosis and bile duct stenosis after stereotactic body radiation therapy for hepatocellular carcinoma., Case reports of portal vein thrombosis and bile duct stenosis after stereotactic body radiation therapy for hepatocellular carcinoma., 44(10), 2014
  3. Stereotactic body radiotherapy for patients with small hepatocellular carcinoma ineligible for resection or ablation therapies., Stereotactic body radiotherapy for patients with small hepatocellular carcinoma ineligible for resection or ablation therapies., 45(4), 2015
  4. Recent advances in radiation oncology., Recent advances in radiation oncology., 19(4), 2014
  5. Role of 3-D conformal radiotherapy for major portal vein tumor thrombosis combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma., Role of 3-D conformal radiotherapy for major portal vein tumor thrombosis combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma., 45(6), 2015
  6. Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy: A propensity score matching analysis., Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy: A propensity score matching analysis., 50(17), 2014
  7. [Stereotactic body radiotherapy]., [Stereotactic body radiotherapy]., 41(13), 2014
  8. Video-assisted thoracoscopic lobectomy versus stereotactic radiotherapy for stage I lung cancer., Video-assisted thoracoscopic lobectomy versus stereotactic radiotherapy for stage I lung cancer., 99(4), 2015
  9. Results of sequential chemoradiotherapy for intracranial germinoma., Results of sequential chemoradiotherapy for intracranial germinoma., 33(6), 2015
  10. The Time Course of Dynamic Computed Tomographic Appearance of Radiation Injury to the Cirrhotic Liver Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma., The Time Course of Dynamic Computed Tomographic Appearance of Radiation Injury to the Cirrhotic Liver Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma., 10(6), 2015
  11. Feasibility of output quality assurance considering gantry angle using "Stealth Chamber"., Polish Journal of Medical Physics and Engineering, 27(4), 299-302, 202112
  12. A prediction model for pathological findings after neoadjuvant chemoradiotherapy for resectable locally advanced esophageal squamous cell carcinoma based on endoscopic images using deep learning, BRITISH JOURNAL OF RADIOLOGY, 95(1135), 2022
  13. Treatment planning comparison between dynamic wave arc and volumetric modulated arc therapies for prostate-cancer treatment, MEDICAL DOSIMETRY, 47(1), 48-53, 2022
  14. Evaluation of two independent dose prediction methods to personalize the automated radiotherapy planning process for prostate cancer, PHYSICS & IMAGING IN RADIATION ONCOLOGY, 21, 24-29, 202201
  15. Deep learning-based auto segmentation using generative adversarial network on magnetic resonance images obtained for head and neck cancer patients, JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 23(5), 202205
  16. Efficacy and safety of chemoradiation therapy using one-shot cisplatin via hepatic arterial infusion for advanced hepatocellular carcinoma with major macrovascular invasion: a single-arm retrospective cohort study, BMC GASTROENTEROLOGY, 22(1), 20220602
  17. Temporal changes and risk factors for esophageal stenosis after salvage radiotherapy in superficial esophageal cancer following non-curative endoscopic submucosal dissection, RADIOTHERAPY AND ONCOLOGY, 166, 65-70, 202201
  18. Stoichiometric CT number calibration using three-parameter fit model for ion therapy, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 99, 22-30, 202207
  19. Stepwise deep neural network (stepwise-net) for head and neck auto-segmentation on CT images, COMPUTERS IN BIOLOGY AND MEDICINE, 143, 202204
  20. Investigating the displacement of radio-active sources during gold-198 grain brachytherapy for hospitalized oral cancer patients, JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 14(2), 115-122, 2022
  21. Functional image guided radiation therapy planning in volumetric modulated arc therapy for patients with malignant pleural mesothelioma, ADVANCES IN RADIATION ONCOLOGY, 2(2), 183-191, 2017
  22. Current update of treatment strategies for borderline resectable pancreatic cancer: a narrative review, JOURNAL OF GASTROINTESTINAL ONCOLOGY, 13(2), 885-897, 202204
  23. Optimal Clinical Target Volume of Radiotherapy Based on Microscopic Extension around the Primary Gross Tumor in Non-Small-Cell Lung Cancer: A Systematic Review, CANCERS, 14(9), 202205
  24. Baseline drift vector of multiple points on body surface using a near-infrared camera, PHYSICAL AND ENGINEERING SCIENCES IN MEDICINE, 45(1), 143-155, 202203
  25. Preliminary Report of Late Recurrences, at 5 Years or More, after Stereotactic Body Radiation Therapy for Non-small Cell Lung Cancer, JOURNAL OF THORACIC ONCOLOGY, 7(2), 453-456, 201202
  26. Functional Image-Guided Radiotherapy Planning in Respiratory-Gated Intensity-Modulated Radiotherapy for Lung Cancer Patients With Chronic Obstructive Pulmonary Disease, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 82(4), E663-E670, 20120315
  27. Dose-Volume Metrics Associated With Radiation Pneumonitis After Stereotactic Body Radiation Therapy for Lung Cancer, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 83(4), E545-E549, 20120715
  28. Long-term outcomes of intraluminal brachytherapy in combination with external beam radiotherapy for superficial esophageal cancer, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 17(3), 263-271, 201206
  29. Treatment Outcome of Medium-Dose-Rate Intracavitary Brachytherapy for Carcinoma of the Uterine Cervix: Comparison With Low-Dose-Rate Intracavitary Brachytherapy, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 84(1), 137-145, 20120901
  30. Detailed dosimetric evaluation of intensity-modulated radiation therapy plans created for stage C prostate cancer based on a planning protocol, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 17(5), 505-511, 201210
  31. Coronary Artery Calcium Scoring on Different 64-detector Scanners Using a Low-tube Voltage (80 kVp), ACADEMIC RADIOLOGY, 19(11), 1402-1407, 201211
  32. Time-dependent cell disintegration kinetics in lung tumors after irradiation., Physics in medicine and biology, 53(9), 2413-1423, 20080401
  33. Japanese structure survey of radiaiton oncology in 2005 based on institutional stratification of patterns of care study., International journal of radiaiton oncology biology physics, 72(1), 144-152, 20080901
  34. National structure of radiation oncology in Japan with special reference to desighnated cancer care hospitals, International journal of clinical oncology, 14(3), 244-247, 20090601
  35. Effect of audio coaching on correlation of abdominal displacement with lung tumor motion., Int J Radiat Oncol Biol Phys, 75(2), 558-563, 20091001
  36. Intra-arterial infusion chemotherapy using cisplatin with radiotherapy for Stage III squamous cell carcinoma of the cervix., Int J Radiat Oncol Biol Phys, 75(2), 369-377, 20091001
  37. Radiation therapy for esophageal cancer in Japan: results of the Patterns of Care Study 1999-2001., Int J Radiat Oncol Biol Phys., 75(2), 357-363, 20091001
  38. Survey of stereotactic body radiation therapy in Japan by the Japan 3-D Conformal External Beam Radiotherapy Group, Int J Radiat Oncol Biol Phys, 75(2), 343-347, 20091001
  39. Results of a preliminary study using hypofractionated involved field radiation therapy and concurrent carboplatin/paclitaxel in the treatment of locally advanced Non-Small-Cell lung cancer, Int J Clin Oncol,, 14(5), 408-415, 20091001
  40. Clinical Outcomes of Stereotactic Body Radiotherapy for Small Lung Lesions Clinically Diagnosed as Primary Lung Cancer on Radiologic Examination, Int J Radiat Oncol Biol Phys, 75(3), 683-687, 20091101
  41. Stereotactic Body Radiation Therapy for Early Non-Small Cell Lung Cancer., Front Radiat Ther Oncol, 42, 94-114, 20100101
  42. Prognostic Factors in Stereotactic Body Radiotherapy for Non-Small-Cell Lung Cancer., International Journal of Radiation Oncology= Biology= Physics, 79(4), 1104-1111, 20110301
  43. Radiation pneumonitis in patients with lung and mediastinal tumours: a retrospective study of risk factors focused on pulmonary emphysema., The British Journal of Radiology, 85(1010), 135-141, 20110201
  44. Characterization of FDG-PET images after stereotactic body radiation therapy for lung cancer, 97(2), 200-204, 20110401
  45. Detailed dosimetric evaluation of intensity-modulated radiation therapy plans created for stage C prostate cancer based on a planning protocol., International journal of clinical oncology, 20110901
  46. Stereotactic body radiotherapy (SBRT) for operable stage I non–small-cell lung cancer: Can SBRT be comparable to surgery?, International Journal of Radiation Oncology= Biology= Physics, 81(5), 1352-1358, 20111201
  47. Six-year experience of permanent prostate brachytherapy for clinically localized prostate cancer., Hiroshima Journal of Medical Science, 60(4), 51-56, 20111201
  48. In reply to Drs. Atalar, Caglar, and Ozyar, International Journal of Radiation Oncology= Biology= Physics, 82(2), 521, 20120201
  49. Geometrical differences in target volumes between slow CT and 4D CT imaging in stereotactic body radiotherapy for lung tumors in the upper and middle lobe, MEDICAL PHYSICS, 35(9), 4142-4148, 200809
  50. National structure of radiation oncology in Japan with special reference to designated cancer care hospitals, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 14(3), 237-244, 200906
  51. SURVEY OF STEREOTACTIC BODY RADIATION THERAPY IN JAPAN BY THE JAPAN 3-D CONFORMAL EXTERNAL BEAM RADIOTHERAPY GROUP, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 75(2), 343-347, 20091001
  52. RADIATION THERAPY FOR ESOPHAGEAL CANCER IN JAPAN: RESULTS OF THE PATTERNS OF CARE STUDY 1999-2001, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 75(2), 357-363, 20091001
  53. EFFECT OF AUDIO COACHING ON CORRELATION OF ABDOMINAL DISPLACEMENT WITH LUNG TUMOR MOTION, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 75(2), 558-563, 20091001
  54. CLINICAL OUTCOMES OF STEREOTACTIC BODY RADIOTHERAPY FOR SMALL LUNG LESIONS CLINICALLY DIAGNOSED AS PRIMARY LUNG CANCER ON RADIOLOGIC EXAMINATION, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 75(3), 683-687, 20091101
  55. Results of a preliminary study using hypofractionated involved-field radiation therapy and concurrent carboplatin/paclitaxel in the treatment of locally advanced non-small-cell lung cancer, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 14(5), 408-415, 200910
  56. Impact of multileaf collimator width on intraprostatic dose painting plans for dominant intraprostatic lesion of prostate cancer, JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 11(4), 144-154, 2010
  57. Characterization of FDG-PET images after stereotactic body radiation therapy for lung cancer, RADIOTHERAPY AND ONCOLOGY, 97(2), 200-204, 201011
  58. STEREOTACTIC RADIOTHERAPY OF PRIMARY LUNG CANCER AND OTHER TARGETS: RESULTS OF CONSULTANT MEETING OF THE INTERNATIONAL ATOMIC ENERGY AGENCY, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 79(3), 660-669, 20110301
  59. PROGNOSTIC FACTORS IN STEREOTACTIC BODY RADIOTHERAPY FOR NON-SMALL-CELL LUNG CANCER, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 79(4), 1104-1111, 20110315
  60. Clinical outcome of esophageal varices after hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with major portal vein tumor thrombus, HEPATOLOGY RESEARCH, 41(11), 1046-1056, 201111
  61. STEREOTACTIC BODY RADIOTHERAPY (SBRT) FOR OPERABLE STAGE I NON SMALL-CELL LUNG CANCER: CAN SBRT BE COMPARABLE TO SURGERY?, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 81(5), 1352-1358, 20111201
  62. Radiation pneumonitis in patients with lung and mediastinal tumours: a retrospective study of risk factors focused on pulmonary emphysema, BRITISH JOURNAL OF RADIOLOGY, 85(1010), 135-141, 201202
  63. Hepatic arterial infusion chemotherapy using 5-fluorouracil and systemic interferon-a for advanced hepatocellular carcinoma in combination with or without three-dimensional conformal radiotherapy to venous tumor thrombosis in hepatic vein or inferior vena cava, HEPATOLOGY RESEARCH, 42(5), 442-453, 201205
  64. Dynamic computed tomography appearance of tumor response after stereotactic body radiation therapy for hepatocellular carcinoma: How should we evaluate treatment effects?, HEPATOLOGY RESEARCH, 43(7), 717-727, 201307
  65. Stereotactic body radiation therapy combined with transcatheter arterial chemoembolization for small hepatocellular carcinoma, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 28(3), 530-536, 201303
  66. Stereotactic Body Radiotherapy for Early Stage Lung Cancer, CANCER RESEARCH AND TREATMENT, 45(3), 155-161, 201309
  67. Effectiveness of Cervical Cancer Screening Based on a Mathematical Screening Model using data from the Hiroshima Prefecture Cancer Registry, ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 14(8), 4897-4902, 2013
  68. Pilot Study of Stereotactic Body Radiation Therapy Combined with Transcatheter Arterial Chemoembolization for Small Hepatocellular Carcinoma, HEPATO-GASTROENTEROLOGY, 61(129), 31-36, 2014
  69. Reorganization of Damaged Chromatin by the Exchange of Histone Variant H2A.Z-2, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 89(4), 736-744, 20140715
  70. Safety and effectiveness of stereotactic body radiotherapy for a clinically diagnosed primary stage I lung cancer without pathological confirmation, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 19(5), 814-821, 201410
  71. Time-Adjusted Internal Target Volume: A Novel Approach Focusing on Heterogeneity of Tumor Motion Based on 4-Dimensional Computed Tomography Imaging for Radiation Therapy Planning of Lung Cancer, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 89(5), 1129-1137, 20140801
  72. Case reports of portal vein thrombosis and bile duct stenosis after stereotactic body radiation therapy for hepatocellular carcinoma, HEPATOLOGY RESEARCH, 44(10), E273-E278, 201410
  73. Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy: A propensity score matching analysis, EUROPEAN JOURNAL OF CANCER, 50(17), 2932-2938, 201411
  74. Video-Assisted Thoracoscopic Lobectomy Versus Stereotactic Radiotherapy for Stage I Lung Cancer, ANNALS OF THORACIC SURGERY, 99(4), 1122-1129, 20150327
  75. Clinical experience of volumetric modulated arc therapy for malignant pleural mesothelioma after extrapleural pneumonectomy, JOURNAL OF RADIATION RESEARCH, 56(2), 315-324, 201503
  76. Stereotactic body radiotherapy for patients with small hepatocellular carcinoma ineligible for resection or ablation therapies, HEPATOLOGY RESEARCH, 45(4), 378-386, 201504
  77. Role of 3-D conformal radiotherapy for major portal vein tumor thrombosis combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma, HEPATOLOGY RESEARCH, 45(6), 607-617, 201506
  78. The Time Course of Dynamic Computed Tomographic Appearance of Radiation Injury to the Cirrhotic Liver Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma, PLOS ONE, 10(6), e0125231, 20150611
  79. Results of sequential chemoradiotherapy for intracranial germinoma, JAPANESE JOURNAL OF RADIOLOGY, 33(6), 336-343, 201506
  80. Results of Neoadjuvant Chemoradiotherapy With Docetaxel and 5-Fluorouracil Followed by Esophagectomy to Treat Locally Advanced Esophageal Cancer, ANNALS OF THORACIC SURGERY, 99(6), 1887-1893, 201506
  81. Stereotactic body radiotherapy, 名 Japanese Journal of Cancer and Chemotherapy, 41(13), 2543-2545, 201412
  82. Radiation-induced pyogenic vertebral osteomyelitis after re-irradiation for para-aortic lymph node metastases in a patient with cervical cancer, International Cancer Conference Journal, 3(4), 207-210, 201410
  83. Time-adjusted internal target volume: a novel approach focusing on heterogeneity of tumor motion based on 4-dimensional computed tomography imaging for radiation therapy planning of lung cancer., Int J Radiat Oncol Biol Phys, 89(5), 1129-1137, 201408
  84. Reorganization of damaged chromatin by the exchange of histone variant H2A.Z-2., Int J Radiat Oncol Biol Phys., 89(4), 736-744, 201407
  85. Long-term results of definitive concurrent chemoradiotherapy for patients with esophageal submucosal cancer (T1bN0M0), INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 20(5), 897-904, 201510
  86. The development of stereotactic body radiotherapy in the past decade: a global perspective, FUTURE ONCOLOGY, 11(19), 2721-2733, 2015
  87. Clinical utility of gadoxetate disodium-enhanced hepatic MRI for stereotactic body radiotherapy of hepatocellular carcinoma, JAPANESE JOURNAL OF RADIOLOGY, 33(10), 627-635, 201510
  88. Combined Ventilation and Perfusion Imaging Correlates With the Dosimetric Parameters of Radiation Pneumonitis in Radiation Therapy Planning for Lung Cancer, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 93(4), 778-787, 20151115
  89. Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 93(5), 989-996, 20151201
  90. Cerebral blood flow in transient hypothyroidism after thyroidectomy: Arterial spin labeling magnetic resonance study, NEUROENDOCRINOLOGY LETTERS, 36(6), 545-551, 2015
  91. Evaluation of adverse events in atomic bomb survivors receiving curative-intent radiation therapy from 2005 to 2010, RADIOTHERAPY AND ONCOLOGY, 118(1), 60-64, 201601
  92. Availability of applying diaphragm matching with the breath-holding technique in stereotactic body radiation therapy for liver tumors, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 32(4), 557-561, 201604
  93. Long-term results after 12-year follow-up of patients treated with whole-breast and boost irradiation after breast-conserving surgery, JAPANESE JOURNAL OF RADIOLOGY, 34(9), 595-604, 201609
  94. Simple quality assurance method of dynamic tumor tracking with the gimbaled linac system using a light field, JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 17(5), 177-183, 2016
  95. Lipiodol impact on dose distribution in liver SBRT after TACE, Medeical Physics, 42(2), 3212-3212, 201506
  96. Treatment outcomes of patients with FIGO Stage I/II uterine cervical cancer treated with definitive radiotherapy: a multi-institutional retrospective research study., J Radiat Res, 56(5), 841-848, 201509
  97. Role of definitive chemoradiotherapy using docetaxel and 5-fluorouracil in patients with unresectable locally advanced esophageal squamous cell carcinoma: a phase II study., Diseases of the Esophagus, 2015
  98. Clinical outcomes of radiotherapy for esophageal cancer between 2004 and 2008: the second survey of the Japanese Radiation Oncology Study Group (JROSG)., Int J Clin Oncol, 21(1), 88-94, 201602
  99. Beam Characteristics at Low Dose Monitor Unit Settings for Vero4DRT,, International Journal of Medical Physics, Clinical Engineering and Radiation Oncology, 4, 284-289, 201504
  100. Stereotactic body radiotherapy versus lobectomy for operable clinical stage IA lung adenocarcinoma: comparison of survival outcomes in two clinical trials with propensity score analysis (JCOG1313-A), JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 46(8), 748-753, 201608
  101. Gafchromic EBT-XD film: Dosimetry characterization in high-dose, volumetric-modulated arc therapy, JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 17(6), 312-322, 2016
  102. Role of definitive chemoradiotherapy using docetaxel and 5-fluorouracil in patients with unresectable locally advanced esophageal squamous cell carcinoma: a phase II study, DISEASES OF THE ESOPHAGUS, 29(8), 1115-1120, 2016
  103. Method of evaluating respiratory induced organ motion by vector volume histogram, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 32(12), 1570-1574, 201612
  104. Absorbed dose and image quality of Varian TrueBeam CBCT compared with OBI CBCT, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 32(12), 1628-1633, 201612
  105. Quality assurance of a gimbaled head swing verification using feature point tracking, JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 18(1), 49-52, 201701
  106. Marginal prescription equivalent to the isocenter prescription in lung stereotactic body radiotherapy: preliminary study for Japan Clinical Oncology Group trial (JCOG1408), JOURNAL OF RADIATION RESEARCH, 58(1), 149-154, 201701
  107. Dosimetric impact of Lipiodol in stereotactic body radiation therapy on liver after trans-arterial chemoembolization, MEDICAL PHYSICS, 44(1), 342-348, 201701
  108. A randomized Phase III trial of comparing two dose-fractionations stereotactic body radiotherapy (SBRT) for medically inoperable Stage IA non-small cell lung cancer or small lung lesions clinically diagnosed as primary lung cancer: Japan Clinical Oncology Group Study JCOG1408 (J-SBRT trial), JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 47(3), 277-281, 201703
  109. Dose Escalation Improves Outcome in Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Colorectal Cancer, ANTICANCER RESEARCH, 37(5), 2709-2713, 201705
  110. Functional image-guided stereotactic body radiation therapy planning for patients with hepatocellular carcinoma, MEDICAL DOSIMETRY, 42(2), 97-103, 2017
  111. Accidental overexposure related to new radiation therapy technologies, JOURNAL OF RADIATION ONCOLOGY, 6(2), 117-132, 201706
  112. Evaluation of beam modeling for small fields using a flattening filter-free beam, RADIOLOGICAL PHYSICS AND TECHNOLOGY, 10(1), 33-40, 201703
  113. Quality assurance for dynamic tumor tracking using the Vero4DRT system, International Journal of Cancer Therapy and Oncology, 4(1), 49-52, 2016
  114. Impact of reduction of flux overlap region on kilovoltage cone-beam computed tomography image quality and patients’ exposure dose., Rep Pract Oncol Radiother, 21(5), 460-465, 201608
  115. Availability of applying diaphragm matching with the breath-holding technique in stereotactic body radiation therapy for liver tumors., Phys Med., 32(4), 557-561, 201604
  116. Dataset for Beam Commissioning of the Vero4DRT System,, International Journal of Medical Physics, Clinical Engineering and Radiation Oncology, 70-77, 201605
  117. Hepatectomy after down-staging of hepatocellular carcinoma with portal vein tumor thrombus using chemoradiotherapy: A retrospective cohort study., Int J Surg, 44, 223-228, 201708
  118. Efficacy of robust optimization plan with partial-arc VMAT for photon volumetric-modulated arc therapy: A phantom study., J Appl Clin Med Phys, Epub ahead of print, 2017
  119. Evaluation of cone-beam computed tomography image quality assurance for Vero4DRT system., Rep Pract Oncol Radiother, 22(3), 258-263, 2017
  120. Clinical outcomes of stereotactic body radiotherapy for elderly patients with hepatocellular carcinoma., Hepatol Res, Epub ahead of print, 2017
  121. Phase I study of stereotactic body radiation therapy for centrally located stage IA non-small cell lung cancer (JROSG10-1)., Int J Clin Oncol., Epub ahead of print, 2017
  122. Effect of tumor amplitude and frequency on 4D modeling of Vero4DRT system., Reports of practical oncology and radiotherapy, 22(4), 290-304, 2017
  123. In Regard to Nagata et al., Int J Radiat Oncol Biol Phys., 96(4), 1320-1320, 201607
  124. Impact of reduction of flux overlap region on kilovoltage cone-beam computed tomography image quality and patients' exposure dose., Rep Pract Oncol Radiother, 21(5), 460-465, 2016
  125. Hepatectomy after down-staging of hepatocellular carcinoma with portal vein tumor thrombus using chemoradiotherapy: A retrospective cohort study, INTERNATIONAL JOURNAL OF SURGERY, 44, 223-228, 201708
  126. Evaluation of cone-beam computed tomography image quality assurance for Vero4DRT system, REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 22(3), 258-263, 2017
  127. Effect of tumor amplitude and frequency on 4D modeling of Vero4DRT system, REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 22(4), 290-294, 2017
  128. Split-VMAT technique to control the expiratory breath-hold time in liver stereotactic body radiation therapy, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 40, 17-23, 201708
  129. Phase I study of stereotactic body radiation therapy for centrally located stage IA non-small cell lung cancer (JROSG10-1), INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 22(5), 849-856, 201710
  130. Clinical outcomes of concurrent chemoradiotherapy with volumetric modulated arc therapy in patients with locally advanced nasopharyngeal carcinoma, JAPANESE JOURNAL OF RADIOLOGY, 35(11), 673-680, 201711
  131. Efficacy of robust optimization plan with partial-arc VMAT for photon volumetric-modulated arc therapy: A phantom study, JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 18(5), 97-103, 201709
  132. Impact of deformable image registration accuracy on thoracic images with different regularization weight parameter settings, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 42, 108-111, 201710
  133. Proposed patient motion monitoring system using feature point tracking with a web camera, AUSTRALASIAN PHYSICAL & ENGINEERING SCIENCES IN MEDICINE, 40(4), 939-942, 201712
  134. Accuracy of the raw-data-based effective atomic numbers and monochromatic CT numbers for contrast medium with a dual-energy CT technique, BRITISH JOURNAL OF RADIOLOGY, 91(1082), 2018
  135. Clinical outcomes of stereotactic body radiotherapy for elderly patients with hepatocellular carcinoma, HEPATOLOGY RESEARCH, 48(2), 193-204, 201802
  136. A Chemical Modulator of p53 Transactivation that Acts as a Radioprotective Agonist, MOLECULAR CANCER THERAPEUTICS, 17(2), 432-442, 201802
  137. Energy spectrum and dose enhancement due to the depth of the Lipiodol position using flattened and unflattened beams, REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 23(1), 50-56, 2018
  138. Effect of secondary electron generation on dose enhancement in Lipiodol with and without a flattening filter, JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 19(2), 211-217, 201803
  139. Interfractional diaphragm changes during breath-holding in stereotactic body radiotherapy for liver cancer, REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 23(2), 84-90, 2018
  140. Tolerance levels of CT number to electron density table for photon beam in radiotherapy treatment planning system, JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 19(1), 271-275, 201801
  141. Relative biological effectiveness study of Lipiodol based on microdosimetric-kinetic model, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 46, 89-95, 201802
  142. Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy Combined with Radiotherapy and Sorafenib for Advanced Hepatocellular Carcinoma Patients with Major Portal Vein Tumor Thrombosis, ONCOLOGY, 94(4), 215-222, 2018
  143. Evaluation of Prognostic Factors for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery, WORLD JOURNAL OF SURGERY, 42(5), 1496-1505, 201805
  144. Stereotactic body radiotherapy (SBRT) for Stage I lung cancer, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 48(5), 405-409, 201805
  145. Results of a multi-institutional, randomized, non-inferiority, phase III trial of accelerated fractionation versus standard fractionation in radiation therapy for T1-2N0M0 glottic cancer: Japan Clinical Oncology Group Study JCOG0701), ANNALS OF ONCOLOGY, 29(4), 992-997, 201804
  146. 4D modeling in a gimbaled linear accelerator by using gold anchor markers, REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 23(3), 183-188, 2018
  147. Impact of reduction of flux overlap region on kilovoltage cone-beam computed tomography image quality and patients' exposure dose, REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 21(5), 460-465, 2016
  148. Image quality and absorbed dose comparison of single- and dual-source cone-beam computed tomography, JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 19(3), 360-366, 201805
  149. A novel verification method using a plastic scintillator imagining system for assessment of gantry sag in radiotherapy, MEDICAL PHYSICS, 45(6), 2411-2424, 201806
  150. Quantifying esophageal motion during free-breathing and breath-hold using fiducial markers in patients with early-stage esophageal cancer, PLOS ONE, 13(6), 20180611
  151. Preoperative prediction of a pathologic complete response of esophageal squamous cell carcinoma to neoadjuvant chemoradiotherapy, SURGERY, 164(1), 40-48, 201807
  152. Long-term outcome of stereotactic body radiotherapy for patients with small hepatocellular carcinoma, HEPATOLOGY RESEARCH, 48(9), 701-707, 201808
  153. Stereotactic body radiotherapy to treat small lung lesions clinically diagnosed as primary lung cancer by radiological examination: A prospective observational study, LUNG CANCER, 122, 107-112, 201808
  154. Hepatectomy versus stereotactic body radiotherapy for primary early hepatocellular carcinoma: A propensity-matched analysis in a single institution, SURGERY, 164(2), 219-226, 201808
  155. Automatic contrast medium extraction system using electron density data with dual-energy CT, BRITISH JOURNAL OF RADIOLOGY, 91(1090), 2018
  156. Comparison of Stereotactic Body Radiation Therapy Combined With or Without Transcatheter Arterial Chemoembolization for Patients With Small Hepatocellular Carcinoma Ineligible for Resection or Ablation Therapies, TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 17, 20180701
  157. Evaluation of optimization workflow using design of experiment (DoE) for various field configurations in volumetric-modulated arc therapy, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 54, 34-41, 201810
  158. Clinical features of prostate-specific antigen bounce after I-125 brachytherapy for prostate cancer, JOURNAL OF RADIATION RESEARCH, 59(5), 649-655, 201809
  159. Long-term results of neoadjuvant chemoradiotherapy using cisplatin and 5-fluorouracil followed by esophagectomy for resectable, locally advanced esophageal squamous cell carcinoma, JOURNAL OF RADIATION RESEARCH, 59(5), 616-624, 201809
  160. Gantry angle classification with a fluence map in intensity-modulated radiotherapy for prostate cases using machine learning, POLISH JOURNAL OF MEDICAL PHYSICS AND ENGINEERING, 24(4), 165-169, 201812
  161. Development of geometrically ideal dose distribution as a reference for treatment planning in VMAT using filtered back-projection method, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 57, 115-122, 201901
  162. Predictive gamma passing rate by dose uncertainty potential accumulation model, MEDICAL PHYSICS, 46(2), 999-1005, 201902
  163. Volumetric modulated arc therapy with robust optimization for larynx cancer, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 58, 54-58, 201902
  164. A novel risk analysis of clinical reference dosimetry based on failure modes and effects analysis, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 58, 59-65, 201902
  165. Early Recurrence and Cancer Death After Trimodal Therapy for Esophageal Squamous Cell Carcinoma, ANTICANCER RESEARCH, 39(3), 1433-1440, 201903
  166. Effect of image quality on correlation modeling error using a fiducial marker in a gimbaled linear accelerator, REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 24(2), 233-238, 2019
  167. Automatic calibration of an arbitrarily-set near-infrared camera for patient surface respiratory monitoring, MEDICAL PHYSICS, 46(3), 1163-1174, 201903
  168. How to Improve the Conspicuity of Breast Tumors on Computed High b-value Diffusion-weighted Imaging, MAGNETIC RESONANCE IN MEDICAL SCIENCES, 18(2), 119-125, 2019
  169. A primary analysis of a multicenter, prospective, single-arm, confirmatory trial of hypofractionated whole breast irradiation after breast-conserving surgery in Japan: JCOG0906, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 49(1), 57-62, 201901
  170. Concurrent chemoradiotherapy for locally advanced squamous cell carcinoma of the cervix in a uterus didelphys with vaginal septum, JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 11(2), 180-188, 2019
  171. Clinical Significance of F-18-Fluorodeoxyglucose-Positron Emission Tomography-Positive Lymph Nodes to Outcomes of Trimodal Therapy for Esophageal Squamous Cell Carcinoma, ANNALS OF SURGICAL ONCOLOGY, 26(6), 1869-1878, 201906
  172. Investigation of the applicability of the ESR nail dosimetry for assessment of accidental exposure in medical facilities, RADIATION MEASUREMENTS, 124, 91-97, 201905
  173. Tolerance levels of mass density for CT number calibration in photon radiation therapy, JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 20(6), 45-52, 201906
  174. Photon and electron backscatter dose and energy spectrum analysis around Lipiodol using flattened and unflattened beams, JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 20(6), 178-183, 201906
  175. Automatic gas detection in prostate cancer patients during image-guided radiation therapy using a deep convolutional neural network, Physica Medica, 64, 24-28, 2019
  176. 放射線科医の魅力とリクルート 放射線治療医編, 臨床画像, 34(7), 889-891, 201807
  177. Comparison of clinical outcome between computed tomography-based image-guided brachytherapy and two-dimensional-based brachytherapy for cervical cancer, GYNECOLOGIC ONCOLOGY REPORTS, 29, 79-82, 201908
  178. Improving automatic contrast agent extraction system using monochromatic CT number, AUSTRALASIAN PHYSICAL & ENGINEERING SCIENCES IN MEDICINE, 42(3), 819-826, 201909
  179. Automatic gas detection in prostate cancer patients during image-guided radiation therapy using a deep convolutional neural network, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 64, 24-28, 201908
  180. Evaluation of raw-data-based and calculated electron density for contrast media with a dual-energy CT technique, REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 24(5), 499-506, 2019
  181. Stereotactic Body Radiotherapy for Oligometastatic Disease in Non-small Cell Lung Cancer, FRONTIERS IN ONCOLOGY, 9, 20191112
  182. Scintillator screen for measuring dose distribution in scanned carbon-ion therapy, RADIATION MEASUREMENTS, 129, 201910
  183. MRI appearance change during stereotactic radiotherapy for large brain metastases and importance of treatment plan modification during treatment period, JAPANESE JOURNAL OF RADIOLOGY, 37(12), 850-859, 201912
  184. Biological dose-enhancement analysis with Monte Carlo simulation for Lipiodol for photon beams, REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 24(6), 681-687, 2019
  185. Scores of Child-Pugh Classification Impact Overall Survival After Stereotactic Body Radiation Therapy for Primary and Metastatic Liver Tumors, JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 10(2), 101-105, 2020
  186. An overview of stereotactic body radiation therapy for hepatocellular carcinoma, EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 14(4), 271-279, 20200402
  187. Predictive gamma passing rate for three-dimensional dose verification with finite detector elements via improved dose uncertainty potential accumulation model, MEDICAL PHYSICS, 47(3), 1349-1356, 202003
  188. Assessment of biological dosimetric margin for stereotactic body radiation therapy, JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 21(4), 31-41, 202004
  189. Scintillator screen for measuring low-dose halo in scanning carbon-ion therapy, RADIATION MEASUREMENTS, 133, 202004
  190. Development of a CT number calibration audit phantom in photon radiation therapy: A pilot study, MEDICAL PHYSICS, 47(4), 1509-1522, 202004
  191. Effect of bevacizumab against cystic components of brain tumors, CANCER MEDICINE, 8(15), 6519-6527, 201911
  192. Isolated cardiac metastases of hepatocellular carcinoma after resection: a case report, CLINICAL JOURNAL OF GASTROENTEROLOGY, 13(3), 421-427, 202006
  193. Analysis of cardiac toxicity after definitive chemoradiotherapy for esophageal cancer using a biological dose-volume histogram, JOURNAL OF RADIATION RESEARCH, 61(2), 298-306, 202003
  194. Effectiveness of salvage radiotherapy for superficial esophageal Cancer after non-curative endoscopic resection, RADIATION ONCOLOGY, 15(1), 20200601
  195. Characterization of robust optimization for VMAT plan for liver cancer, REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 25(3), 376-381, 2020
  196. Evaluation of metal artefact techniques with same contrast scale for different commercially available dual-energy computed tomography scanners, PHYSICAL AND ENGINEERING SCIENCES IN MEDICINE, 43(2), 539-546, 202006
  197. Dose compensation based on biological effectiveness due to interruption time for photon radiation therapy, BRITISH JOURNAL OF RADIOLOGY, 93(1111), 2020
  198. A Single Institution's Experience of Definitive Radiotherapy Using Volumetric-modulated Arc Therapy for Hypopharyngeal Cancers, ANTICANCER RESEARCH, 40(7), 4183-4190, 202007
  199. Synthesized effective atomic numbers for commercially available dual-energy CT, REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 25(4), 692-697, 2020
  200. Evaluation of interbreath-hold lung tumor position reproducibility with vector volume histogram using the breath-hold technique, MEDICAL DOSIMETRY, 45(3), 252-255, 2020
  201. Fingernail dosimetry using electron spin resonance for radiation disaster response, Journal of Physics, 1248, '012072, 201906
  202. Imaging Cherenkov emission for quality assurance of high-dose-rate brachytherapy, SCIENTIFIC REPORTS, 10(1), 20200227
  203. Predictions of Pathological Features and Recurrence Based on FDG-PET Findings of Esophageal Squamous Cell Carcinoma after Trimodal Therapy, ANNALS OF SURGICAL ONCOLOGY, 27(11), 4422-4430, 202010
  204. A case of advanced HCC treated with lenvatinib after hepatic arterial infusion chemotherapy combined with radiation therapy treatment for portal vein tumor thrombosis in the main trunk, CLINICAL JOURNAL OF GASTROENTEROLOGY, 13(5), 839-843, 202010
  205. Risk factors for severe gastrointestinal toxicity in patients receiving palliative radiotherapy for metastatic bone tumors: association with the use of molecular-targeted agents, JOURNAL OF RADIATION RESEARCH, 61(4), 629-634, 202007
  206. Effectiveness of robust optimization in volumetric modulated arc therapy using 6 and 10 MV flattening filter-free beam therapy planning for lung stereotactic body radiation therapy with a breath-hold technique, JOURNAL OF RADIATION RESEARCH, 61(4), 575-585, 202007
  207. Nationwide survey of radiation therapy in Japan for lung cancer complicated with interstitial lung disease, JOURNAL OF RADIATION RESEARCH, 61(4), 563-574, 202007
  208. Long-term outcomes of induction chemotherapy followed by chemoradiotherapy using volumetric-modulated arc therapy as an organ preservation approach in patients with stage IVA-B oropharyngeal or hypopharyngeal cancers, JOURNAL OF RADIATION RESEARCH, 61(4), 554-562, 202007
  209. A Multi-Institutional Retrospective Study of Repeated Stereotactic Body Radiation Therapy for Intrahepatic Recurrent Hepatocellular Carcinoma, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 108(5), 1265-1275, 20201201
  210. What motivated medical students and residents to become radiation oncologists in Japan?-Questionnaire report by the radiotherapy promotion committee of JASTRO, JOURNAL OF RADIATION RESEARCH, 61(5), 727-732, 202009
  211. Hybrid volumetric-modulated arc therapy for postoperative breast cancer including regional lymph nodes: the advantage of dosimetric data and safety of toxicities, JOURNAL OF RADIATION RESEARCH, 61(5), 747-754, 202009
  212. Image synthesis with deep convolutional generative adversarial networks for material decomposition in dual-energy CT from a kilovoltage CT, COMPUTERS IN BIOLOGY AND MEDICINE, 128, 202101
  213. Evaluation of optimization workflow using custom-made planning through predicted dose distribution for head and neck tumor treatment, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 80, 167-174, 202012
  214. Long-term results of definitive chemoradiotherapy for unresectable locally advanced esophageal squamous cell carcinoma, JOURNAL OF RADIATION RESEARCH, 62(1), 142-148, 202101
  215. Predicting the Local Response of Metastatic Brain Tumor to Gamma Knife Radiosurgery by Radiomics With a Machine Learning Method, FRONTIERS IN ONCOLOGY, 10, 20210111
  216. Distribution of Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma After Trimodal Therapy, ANNALS OF SURGICAL ONCOLOGY, 28(3), 1798-1807, 202103
  217. Formulation of objective indices to quantify machine failure risk analysis for interruptions in radiotherapy, JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 22(1), 165-173, 202101
  218. Verification system for intensity-modulated radiation therapy with scintillator, PHYSICAL AND ENGINEERING SCIENCES IN MEDICINE, 44(1), 9-21, 202103
  219. T2-FLAIR Mismatch Sign and Response to Radiotherapy in Diffuse Intrinsic Pontine Glioma, PEDIATRIC NEUROSURGERY, 56(1), 1-9, 202103
  220. Evaluating Individual Radiosensitivity for the Prediction of Acute Toxicities of Chemoradiotherapy in Esophageal Cancer Patients, RADIATION RESEARCH, 195(3), 244-252, 202103
  221. Image synthesis of monoenergetic CT image in dual-energy CT using kilovoltage CT with deep convolutional generative adversarial networks, JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 22(4), 184-192, 202104
  222. Hepatic Arterial Infusion Chemotherapy Combined with Radiation Therapy for Advanced Hepatocellular Carcinoma with Tumor Thrombosis of the Main Trunk or Bilobar of the Portal Vein, LIVER CANCER, 10(2), 151-160, 202104
  223. T1-weighted and T2-weighted MRI image synthesis with convolutional generative adversarial networks, REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 26(1), 35-42, 202101
  224. Efficacy and tolerability of preoperative chemoradiotherapy with S-1 alone for locally advanced rectal cancer, JOURNAL OF RADIATION RESEARCH, 62(2), 300-308, 202103
  225. Uncertainty in the positioning of patients receiving treatment for brain metastases and wearing surgical mask underneath thermoplastic mask during COVID-19 crisis, JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 22(6), 274-280, 202106
  226. Predicting the Local Response of Esophageal Squamous Cell Carcinoma to Neoadjuvant Chemoradiotherapy by Radiomics with a Machine Learning Method Using F-18-FDG PET Images, DIAGNOSTICS, 11(6), 1049-1049, 202106
  227. A prediction model for degree of differentiation for resectable locally advanced esophageal squamous cell carcinoma based on CT images using radiomics and machine-learning, BRITISH JOURNAL OF RADIOLOGY, 94(1124), 20210525-20210525, 2021
  228. Prediction of radiation pneumonitis after definitive radiotherapy for locally advanced non-small cell lung cancer using multi-region radiomics analysis, SCIENTIFIC REPORTS, 11(1), 16232-16232, 20210810
  229. Reduction of margin to compensate the respiratory tumor motion by the analysis of dosimetric internal target volume in lung SBRT with nonuniform volume prescription method, MEDICAL PHYSICS, 48(6), 3200-3207, 202106
  230. Reduction of margin to compensate the respiratory tumor motion by the analysis of dosimetric internal target volume in lung SBRT with nonuniform volume prescription method, MEDICAL PHYSICS, 48(6), 3200-3207, 202106
  231. Successful multimodality treatment for advanced hepatocellular carcinoma with tumor thrombosis of the main portal trunk: a case study, CLINICAL JOURNAL OF GASTROENTEROLOGY, 14(5), 1517-1524, 202110
  232. Treatment outcomes of real-time intraoral sonography-guided implantation technique of Au-198 grain brachytherapy for T1 and T2 tongue cancer, JOURNAL OF RADIATION RESEARCH, 62(5), 871-876, 202109
  233. Impact of pre-treatment C-reactive protein level and skeletal muscle mass on outcomes after stereotactic body radiotherapy for T1N0M0 non-small cell lung cancer: a supplementary analysis of the Japan Clinical Oncology Group study JCOG0403, JOURNAL OF RADIATION RESEARCH, 62(5), 901-909, 202109
  234. Hydrogel spacer shrinkage during external-beam radiation therapy following low-dose-rate brachytherapy for high-risk prostate cancer: a case series, JOURNAL OF MEDICAL CASE REPORTS, 15(1), 296-296, 20210526
  235. Final analysis of a Multicenter Single-Arm Confirmatory Trial of hypofractionated whole breast irradiation after breast-conserving surgery in Japan: JCOG0906, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 51(6), 865-872, 202106
  236. Annealing properties of the PVA-GTA-I gel dosimeter, RADIATION MEASUREMENTS, 149, 202112
  237. Improved cellular automata model shows that indirect apoptotic cell death due to vascular damage enhances the local control of tumors by single fraction high-dose irradiation, BIOMEDICAL PHYSICS & ENGINEERING EXPRESS, 8(1), 015028-015028, 202201
  238. Brachytherapy with Au-198 grains for cancer of the floor of the mouth: relationships between radiation dose and complications, ORAL RADIOLOGY, 38(1), 105-113, 202201
  239. Reirradiation Using Au-198 Grain Brachytherapy for Recurrent Oral Cancer Cases Previously Treated by Definitive Radiotherapy, ANTICANCER RESEARCH, 42(1), 293-300, 202201
  240. Potential benefits of volumetric modulated arc therapy to reduce the incidence of >= grade 2 radiation pneumonitis in radiotherapy for locally advanced non-small cell lung cancer patients, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 51(12), 1729-1735, 202112
  241. Impact on liver position under breath-hold by computed tomography contrast agents in stereotactic body radiotherapy of liver cancer, REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 26(6), 1035-1044, 2021
  242. Investigation of interfractional variation in lung tumor position under expiratory-phase breath hold using cone-b eam compute d tomography in stereotactic body radiation therapy, MEDICAL DOSIMETRY, 46(4), 370-373, 2021

Publications such as books

  1. 2015/08, Stereotactic Body Radiation Therapy, Springer Japan, 2015, 8, Scholarly Book, Compilation, English, Yasushi Nagata, 254

Invited Lecture, Oral Presentation, Poster Presentation

  1. Tolerances of CT number to mass density table for adaptive helical tomotherapy with MVCT, Tsunemine S, Ozawa S, Nakao M, Miura H, Saito A, Kawahara D, Onishi Y, Onishi T, Okawa F, Terai A, Ueda R, Hashiguchi T, Enomoto N, Yamasaki H, Maruta T, Murakami Y, Nagata Y, The 9th Korea-Japan Joint Meeting on Medical, 2021/09/09, Without Invitation, English, Korea-Japan Joint Meeting on Medical, WEB
  2. Long-term follow up of a RCT of Accelerated Radiotherapy for early Glottic Cancer (JCOG 0701), Kodaira T, Kagami Y, Machida R, Shikama N, Ito Y, Ishikura S, Saito Y, Matsumoto Y, Konishi K, Murakami N, Akimoto T, Fukushima Y, Toshiyasu T, Nakagawa K, Nagata Y, Ogawa H, Uno T, Kataoka M, Nishimura Y, European Society for Radiotherapy and Oncology meets Asia 2021 (ESTRO), 2021/08/27, Without Invitation, English, European Society for Radiotherapy and Oncology (ESTRO), WEB
  3. A study of indirect apoptotic death by vascular damage on cell survival after single-fraction radiotherapy by using an improved cellular automata model., Kawahara D, L WU, Nagata Y, Watanabe Y, AAPM 2021(American Association of Physicists in Medicine 63rd annual meeting & exhibition), 2021/07/25, Without Invitation, English, AAPM (American Association of Physicists in Medicine), WEB
  4. Survival prediction of locally advanced non-small cell lung cancer via machine learning techniques based on multi-region radiomics features and clinical risk factors., Nishioka R, Kawahara D, Imano N, Nagata Y, AAPM 2021(American Association of Physicists in Medicine 63rd annual meeting & exhibition), 2021/07/25, Without Invitation, English, WEB
  5. MRI-based multi-region delta-radiomics for prediction of recurrence after chemoradiotherapy in locally advanced cervical cancer., Kawamura M, Kawahara D, Nishibuchi I, Saito A, Yoshida T, Nagata Y, AAPM 2021(American Association of Physicists in Medicine 63rd annual meeting & exhibition), 2021/07/25, Without Invitation, English, AAPM (American Association of Physicists in Medicine), WEB
  6. Prediction of radiation pneumonitis for NSCLC using crop convolutional neural network based model., Kawahara D, Imano N, Nishioka R, Saito A, Nagata Y, AAPM 2021(American Association of Physicists in Medicine 63rd annual meeting & exhibition), 2021/07/25, Without Invitation, English, AAPM(American Association of Physicists in Medicine), WEB
  7. SBRT for lung cancer, Nagata Y, Virtual Training course on SBRT for liver and lung cancers(Mongol NCCM), 2021/06/09, With Invitation, Japanese, National Cancer Center of Mongol
  8. Potential benefits of volumetric modulated arc therapy to reduce the incidence of grade 2 radiation pneumonitis in radiotherapy for locally advanced non-small cell lung cancer patients., Imano N, Kimura T, Kawahara D, Kubo K, Takeuchi Y, Saito A, Nishibuchi I, Murakami Y, Nagata Y, ASTRO 2021(American Society for Therapeutic Radiology and Oncology 63rd the Annual Meeting), 2021/10/24, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, WEB
  9. Survey of IMRT in Japan., Nagata Y, Ozawa S, Kawahara D, Miura H, Nakao M, Murakami Y, Nishibuchi I, ASTRO 2021(American Society for Therapeutic Radiology and Oncology 63rd the Annual Meeting), 2021/10/24, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, WEB
  10. Radiomic analysis for pretreatment prediction of recurrence after radiotherapy in locally advanced cervical cancer., Kawahara D, Nishibuchi I, Kawamura M, Yoshida T, Nagata Y, ASTRO 2021(American Society for Therapeutic Radiology and Oncology 63rd the Annual Meeting), 2021/10/24, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, WEB
  11. Interstitial brachytherapy for locally advanced tongue cancer: Analysis of the long-term Treatment results for survival and complications., Takeuchi Y, Imano N, Nishibuchi I, Kubo K, Murakami Y, Saito A, Kawahara D, Nagata Y, ASTRO 2021(American Society for Therapeutic Radiology and Oncology 63rd the Annual Meeting), 2021/10/24, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, WEB
  12. A prediction model for para-aortic lymph node metastasis in cervical cancer by radiomics analysis using pre-treatment MRI images of the primary tumor., Nishibuchi I,, Kawahara d, Kawamura M, Kubo K, Imano N, Takeuchi Y, Saito A, Murakami Y, Nagata Y, ASTRO 2021(American Society for Therapeutic Radiology and Oncology 63rd the Annual Meeting), 2021/10/24, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, WEB
  13. Sub-region based radiomic analysis for pretreatment prediction of recurrence after radiotherapy in locally advanced cervical cancer, Kawahara D, Nishibuchi I, Kawamura M, Yoshida T, Nagata Y, The 5th Meeting of the Federation of Asian Organizations for Radiation Oncology(FARO), 2021/10/01, Without Invitation, English, the Federation of Asian Organizations for Radiation Oncology(FARO), WEB
  14. Prediction of radiation pneumonitis after definitive radiotherapy for locally advanced non-small cell lung cancer using multi-region radiomics analysis., Imano N, Kawahara D, Nishioka R, Kimura T, Nagata Y, The 5th Meeting of the Federation of Asian Organizations for Radiation Oncology(FARO), 2021/10/01, Without Invitation, English, the Federation of Asian Organizations for Radiation Oncology, WEB
  15. Automatic selection of an absolute-dose verification point for volumetric-modulated arc therapy via dose uncertainty potential accumulation model., Saito A, Nakashima T, Kawahara D, Shiba E, Matsuura T, Fukata K, Miki K, Tsuneda M, Nishio T, Nagata Y, AAPM 2020(American Association of Physicists in Medicine 62nd annual meeting & exhibition), 2020/07/12, Without Invitation, English, American Association of Physicists in Medicine, WEB
  16. Aperture area in IMRT studied via accumulated dose uncertainty potential, Shiba E, Saito A, Furumi M, Kawahara D, Miki K, Murakami Y, Ohguri T, Ozawa S, Tsuneda M, Yahara K, Nishio T, Korogi Y, Nagata Y, AAPM 2020(American Association of Physicists in Medicine 62nd annual meeting & exhibition), 2020/07/12, Without Invitation, English, American Association of Physicists in Medicine, WEB
  17. A study of the effects of vascular damage on tumor volume after hypo-fraction radiotherapy by using a cellular automata model., Kawahara D, Wu L, Nagata Y, Watanabe Y, AAPM 2020(American Association of Physicists in Medicine 62nd annual meeting & exhibition), 2020/07/12, Without Invitation, English, American Association of Physicists in Medicine, WEB
  18. Predictive gamma passing rate of 3D array detector-based VMAT QA via deep learning combining dose distribution and accumulated dose uncertainty potential distribution., Matsuura T, Kawahara D, Saito A, Shiba E, Yamada K, Ozawa S, Nagata Y, AAPM 2020(American Association of Physicists in Medicine 62nd annual meeting & exhibition), 2020/07/12, Without Invitation, English, American Association of Physicists in Medicine, WEB
  19. Predicting BRAF mutation before Gamma Knife radiosurgery by a radiomics analysis, Kawahara D, Jensen A, Nagata Y, Watanabe Y, 2020/05/08, Without Invitation, Japanese
  20. A new work-flow of appropriate planning for VMAT using patient specific template with geometrical ideal dose distribution., Miki K,, Saito A, Kawahara D, Nakashima T, Nishibuchi I, Kimura T, Murakami Y, Nagata Y:, 2020/05/15, Without Invitation, Japanese
  21. Development of an original CT number calibration phantom for postal audit., Nakao M, Ozawa S, Miura H, Yamada K, Habara K, Hayata M, Kusaba H, Tsuji K, Kawahara D, Miki K, Nakashima T, Ochi Y, Tsuda S, Sido M, Morimoto Y, Kawakubo A, Nozaki H, Kubo Y, Toyota Y, Nagata Y:, 2020/05/15, Without Invitation, Japanese
  22. Novel index to predict non-hematologic acute toxicities caused by chemoradiotherapy in esophageal cancer patients., Imano N,, Nishibuchi I, Kameoka T, Ochi M, Takeuchi Y, Takahashi I, Kimura T, Murakami Y, Tashiro S, Nagata Y, 2020/05/15, Without Invitation, Japanese
  23. Survey of stereotactic body radiation therapy in Japan, Nagata Y, Ozawa S, Nakao M, Kawahara D, Kimura T, Murakami Y, ASTRO 2020 (American Society for Therapeutic Radiology and Oncology 62nd the Annual Meeting), 2020/10/24, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, WEB
  24. A machine learning model with radiomics based on PET images to predict pathological response by neoadjuvant chemoradiotherapy for esophageal cancer, Murakami Y, Kawahara D, Imano N, Takahashi I, Takeuchi Y, Nishibuchi I, Kimura T, Nagata Y, ASTRO 2020 (American Society for Therapeutic Radiology and Oncology 62nd the Annual Meeting), 2020/10/24, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, WEB
  25. Temporal change and risk factor of esophageal stenosis after salvage radiotherapy for superficial esophageal cancer with non-curative endoscopic submucosal dissection, Nishibuchi I, Murakami Y, Kameoka T, Ochi M, Imano N, Takeuchi Y, Takahashi I, Kimura T, Nagata Y, ASTRO 2020 (American Society for Therapeutic Radiology and Oncology 62nd the Annual Meeting), 2020/10/24, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, WEB
  26. Association between acute toxicities of chemoradiotherapy and chromosomal aberrations in peripheral blood lymphocytes in esophageal cancer patients, Imano N, Nishibuchi I, Kawabata E, Kinugasa Y, Sakai C, Ishida M, Akita T, Kimura T, Murakami Y, Nagata Y, Tashiro S, ASTRO 2020 (American Society for Therapeutic Radiology and Oncology 62nd the Annual Meeting), 2020/10/24, Without Invitation, English
  27. Interfraction tumor change during stereotactic radiotherapy for large brain metastases and importance of treatment plan modification during treatment period, Kubo K, Kenjo M, Doi Y, Nakao M, Miura H, Ozawa S, Nagata Y, ASTRO 2020 (American Society for Therapeutic Radiology and Oncology 62nd the Annual Meeting), 2020/10/24, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, WEB
  28. Predicting the degree of differentiation for esophageal cancer with radiomics analysis, 2020/10/01, Without Invitation, Japanese
  29. Association of non-hematologic acute toxicities of chemoradiotherapy in esophageal cancer patients with DNA damage., Imano N, 2020/10/01, Without Invitation, Japanese
  30. Novel index to predict non-hematologic acute toxicities caused by chemoradiotherapy in esophageal cancer patients, Imano N, Nishibuchi I, Kinugasa Y, Lin Shi, Sakai C, Ishida M, Murakami Y, Nagata Y, Tashiro S, The 4th International Symposium of the Network-type Joint Usage/Reaerch Center for Radiation Disaster Medical Science, 2020/02/12, Without Invitation, English, the Network-type Joint Usage/Reaerch Center for Radiation Disaster Medical Science
  31. Long-term outcome of definitive chemoradiotherapy for resectable locally advanced esophageal cancer, Nishibuchi I, Murakami Y, Kameoka T, Ochi M, Imano N, Takeuchi Y, Takahashi I, Kimura T, Nagata Y, European Society for Radiotherapy and Oncology meets Asia 2019 (ESTRO), 2019/12/06, Without Invitation, English, European Society for Radiotherapy and Oncology (ESTRO), Singapore
  32. SBRT For Early Stage NSCLC, The 4th Meeting of Federation of Asian Organizations for Radiation Oncology (FARO), 2019/11/13, Without Invitation, English, Federation of Asian Organizations for Radiation Oncology (FARO), Shenzhen, China
  33. The long-term results of interstitial brachytherapy for early to locally advanced tongue cancer., Takeuchi Y, Kameoka T, Ochi M, Imano N, Takahashi I, Nishibuchi I, Kimura T, Murakami Y, Nagata Y, The 4th Meeting of Federation of Asia Organization for Radiation Oncology(FARO), 2019/11/13, Without Invitation, English, Federation of Asia Organization for Radiation Oncology(FARO), Shenzhen, China
  34. Impact of using volumetric modulated arc therapy on radiation pneumonitis in locally advanced non-small cell lung cancer., Imano N, Kimura T, Kameoka T, Ochi M, Takeuchi Y, Takahashi I, Nishibuchi I, Murakami Y, Nagata Y., The 4th Meeting of Federation of Asia Organization for Radiation Oncology(FARO), 2019/11/13, Without Invitation, English, Federation of Asia Organization for Radiation Oncology(FARO), Shenzhen, China
  35. Analysis of the cardiovascular complications after definitive chemoradiotherapy for esophageal cancer using biological dose volume histogram., Takeuchi, Y, Murakami, Y. Adachi, N. Imano, I. Takahashi, I. Nishibuchi, T. Kimura, Y. Nagata, ASTRO 2019 (American Society for Therapeutic Radiology and Oncology 61st the Annual Meeting), 2019/09/15, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, Chicago, America
  36. Analysis of chromosomal aberrations and H2AX Foci in peripheral blood lymphocytes induced by chemoradiotherapy of patients with esophageal cancer., Imano N, Lin Shi, Nishibuchi I, Adachi Y, Takeuchi Y, Takahashi I, Kimura T, Murakami Y, Miki K, Saito A, Tashiro S, Nagata Y., ASTRO 2019 (American Society for Therapeutic Radiology and Oncology 61st the Annual Meeting), 2019/09/15, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, Chicago, America
  37. Automatic gas detection for prostate cancer patient on image guided radiation therapy using a deep convolutional neural network., Miura H,, Ozawa S, Doi Y, Nakao M, Ohnishi K, Kenjo M, Nagata Y., ASTRO 2019 (American Society for Therapeutic Radiology and Oncology 61st the Annual Meeting), 2019/09/15, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, Chicago, America
  38. Long-term results of definitive chemoradiotherapy with elective nodal irradiation using modern radiotherapy technique for resectable locally advanced esophageal cancer., Nishibuchi I, , Murakami Y, Adachi Y, Imano N, Takeuchi Y, Takahashi I, Kimura T, Nagata Y., ASTRO 2019 (American Society for Therapeutic Radiology and Oncology 61st the Annual Meeting), 2019/09/15, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, Chicago, America
  39. Hybrid-VMAT for post-operative breast cancer including regional lymph nodes: The advantage of dosimetric data and safety of toxicities., Doi Y, Nakao M, Miura H, Ozawa S, Kenjo M, Nagata Y., ASTRO 2019 (American Society for Therapeutic Radiology and Oncology 61st the Annual Meeting), 2019/09/15, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, Chicago, America
  40. Development of the MU verification software with the simplified Clarksons method., Yamaguchi R, Nakao M, Ozawa S, Nagata Y., 2019/09/12, Without Invitation, English
  41. Development of prediction dose distribution with deep convolutional neural network for order-made treatment planning., Miki K,, Saito A, Kawahara D, Imano N, Takeuchi Y, Takahashi I, Nishibuchi I, Kimura T, Murakami Y, Nagata Y., 2019/09/12, Without Invitation, English
  42. Challenging of the automated detection of values of irradiated dose to interphase chromosomes with deep learning., Kawate Y, Miki K, Shi LIN, Imano N, Tashiro S, Nagata Y, 2019/09/12, Without Invitation, English
  43. Impact of Using Volumetric Modulated Arc Therapy on Radiation Pneumonitis in Locally Advanced Non-Small Cell Lung Cancer, Imano N, Kimura T, Kameoka T, Ochi M, Takeuchi Y, Takahashi I, Nishibuchi I, Murakami Y, Kawahara D, Miki K, Saito A, Nagata Y, 2019 World Conference on Lung Cancer, 2019/09/07, Without Invitation, English, World Conference on Lung Cancer, Barcelona, Spain
  44. Development of a learning data for predicting three-dimensional gamma passing rate of IMRT using a dose uncertainty potential, Shiba E, Saito A, Furumi M, Kawahara D, Miki K, Murakami Y, Ohguri T, Ozawa S, Tsuneda M, Yahara K, Nishio T, Korogi Y, Nagata Y, AAPM 2019(American Association of Physicists in Medicine 61st annual meeting & exhibition), 2019/07/14, Without Invitation, English, American Association of Physicists in Medicine
  45. Image synthesis in multi-contrast MRI with deep convolutional generative adversarial networks, Kawahara D, Ozawa S, Saito A, Miki K, Murakami Y, Kimura T, Nagata Y, AAPM 2019(American Association of Physicists in Medicine 61st annual meeting & exhibition), 2019/07/14, Without Invitation, English, American Association of Physicists in Medicine, San Antonio, TX America
  46. A quick calibration technique of a near-infrared camera for body surface monitoring, Saito A, Ohashi A, Nishio T, Hashimoto D, Maekawa H, Murakami Y, Ozawa S, Suitani M, Tsuneda M, Ikenaga K, Nagata Y, AAPM 2019(American Association of Physicists in Medicine 61st annual meeting & exhibition), 2019/07/14, Without Invitation, English, American Association of Physicists in Medicine, San Antonio, TX America
  47. A phase II Trial of Stereotactic Body Radiation Therapy for Operable T1N0M0 Non-Small Cell Lung Cancer. Japan ClinicalOncology Group (JCOG0403): Long term follow-up results., Nagata Y, The 7th Japan-Taiwan Radiation Oncology Symposium, 2019/05/11, Without Invitation, English, Tokyo, Japan
  48. Volumetric modulated arc therapy with robust optimization for larynx cancer., Miura H, Doi Y, Ozawa S, Nakao M, Ohnishi K, Kenjo Masahiro, Nagata Y., ESTRO, 2019/04/26, Without Invitation, English, ESTRO, Milan,Italy
  49. A comparison of breast cosmetic evaluation methods in hypofractionated whole-breast irradiation., Nozaki M, Kagami Y, Takahashi M, Machida R, Shibata T, Ito Y, Nishimura Y, Kawaguchi Y, Saito Y, Nagata Y, Matsumoto Y,Akimoto T, Hoiraoka M., ESTRO, 2019/04/26, Without Invitation, English, ESTRO, Milan,Italy
  50. Fractionation effects on the robustness for prostate cancer., Tsubouchi K,, Kawahara D, Nakashima T, Ohno Y, Sumida H, Nagata Y., 2019/04/11, Without Invitation, English
  51. A margin for fractionation effects in stereotactic radiation therapy., Kawahara D, Ozawa S, Tsubouchi K, Ohno Y, Nagata Y., 2019/04/11, Without Invitation, English
  52. SBRT in JAPAN, Nagata Y, HICARE/IAEA International Training Course on Advanced Radiation Therapy (IAEA-RCA Regional Training Course), 2019/02/18, Without Invitation, English, HICARE/IAEA, Hiroshima, Japan
  53. A Simplified Three-Isocenter VMAT for Craniospinal Irradiation, Takahashi I, Adachi Y, Imano N, Takeuchi Y, Nishibuchi I, Miki K, Saito, A , Kimura T, Murakami Y, Nagata Y, European Society for Radiotherapy and Oncology meets Asia 2018 (ESTRO), 2018/12/07, Without Invitation, English, European Society for Radiotherapy and Oncology, Singapore
  54. A simplified three-isocenter VMAT for craniospinal irradiation., Takahashi I, Imano N, Takeuchi Y, Nishibuchi I, Kimura T, Murakami Y, Nagata Y., ASTRO 2018 (American Society for Therapeutic Radiology and Oncology 60th the Annual Meeting), 2018/10/21, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, San Antonio, America
  55. A phase II trial of stereotactic body radiation therapy for operable T1N0M0 Non-Small cell lung cancer; Japan clinical oncology group (JCOG0403); Long term follow-up results., Nagata Y, Hiraoka M, Shibata T, Onishi H, Kokubo M, Karasawa K, Shioyama Y, Onimaru R, Kunieda E, Ishikura S., ASTRO 2018 (American Society for Therapeutic Radiology and Oncology 60th the Annual Meeting), 2018/10/21, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, San Antonio, America
  56. Comparison of stereotactic body radiation therapy combined with or without transcatheter arterial chemoembolization for patients with small hepatocellular carcinoma ineligible for resection or ablation therapies., Kimura T, Doi Y, Aikata H, Imano N, Takeuchi Y, Takahashi I, Nishibuchi I, Katsuta T, Kenjo K, Murakami Y, Awai K, Chayama K, Nagata Y., ASTRO 2018 (American Society for Therapeutic Radiology and Oncology 60th the Annual Meeting), 2018/10/21, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, San Antonio, America
  57. The efficacy and tolerability of S-1 in the treatment of preoperative chemoradiotherapy for locally advanced rectal cancer., Imano N, Nishibuchi I, Takeuchi Y, Takahashi I, Miki K, Saito A, Kimura T, Murakami Y, Nagata Y., ASTRO 2018 (American Society for Therapeutic Radiology and Oncology 60th the Annual Meeting), 2018/10/21, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, San Antonio, America
  58. Salvage radiation therapy with elective nodal irradiation for superficial esophageal cancer after incomplete endoscopic resection., Nishibuchi I, Murakami Y, Imano N, Takeuchi Y, Takahashi I, Kimura T, Nagata Y., ASTRO 2018 (American Society for Therapeutic Radiology and Oncology 60th the Annual Meeting), 2018/10/21, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, San Antonio, America
  59. Vector volume histogram: New method to evaluate deformed organ motion., Miura H, Ozawa S, Doi Y, Kenjo M, Nakao M, Nagata Y., ASTRO 2018 (American Society for Therapeutic Radiology and Oncology 60th the Annual Meeting), 2018/10/21, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, San Antonio, America
  60. A multicenter single-arm confirmatory trial on hypofractionated whole-breast irradiation after breast-conserving surgery., Kawaguchi Y, Nozaki M, Kagami Y, Shibata T, Nakamura K, Ito Y, Nishimura Y, Saito Y, Nagata Y, Matsumo Y, Akimoto T, Nishimura T, Uno T, Tsujino K, Kataoka M, Kodaira T, Shiraishi K, Inoue K, Isohashi F, Hiraoka M., ASTRO 2018 (American Society for Therapeutic Radiology and Oncology 60th the Annual Meeting), 2018/10/21, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, San Antonio, America
  61. Study of Interstitial lung disease and acute exacerbation in patients receiving radiation therapy for lunf cancer in Japan., Hagiwara Y, Nakayama Y, Kato T, Saito Y, Hayakawa K, Nakamura N, Kitamoto Y, Takahashi S, Tsujino K, Kubo N, Tamaki Y, Kusumoto M, Iwasawa T, Nagata Y., IASLC 19th World Conference on Lung Cancer, 2018/09/23, Without Invitation, English, IASLC, Tronto, Canada
  62. Particle therapy & Immuno-RT, Nagata Y, The National Radiation Oncology Meeting on Advanced Radiation Oncology technologist based on introduction of LINACs in Mongolia, 2018/09/19, Without Invitation, English, National Cancer Center in Mongolia, Mongolia
  63. The Efficacy and Tolerability of S-1 in the Treatment of Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer., Imano N, Murakami Y, Nishibuchi I, Adachi Y, Takeuchi Y, Takahashi I, Kimura T, Nagata Y., The 3rd Meeting of the Federation of Asian Organizations for Radiation Oncology(FARO), 2018/09/06, Without Invitation, English, the Federation of Asian Organizations for Radiation Oncology(FARO), Bali, Indonesia
  64. Biological dose enhancement using lipiodol in liver SBRT after TACE., Kawahara D, Nakano H, Ozawa S, Saito A, Kimura T, Tsuneda M, Hioki K, Masuda H, Ochi Y, Nakashima T, Ohno Y, Murakami Y, Nagata Y., AAPM 2018(American Association of Physicists in Medicine 60th annual meeting & exhibition), 2018/07/29, Without Invitation, English, American Association of Physicists in Medicine, Nashville TN, America
  65. Structure and aperture-based robustness estimation for volumetric modulated arc therapy., Mori M, Saito A, Kawahara D, Miki K, Murakami Y, Nakashima T, Okumura T, Nagata Y., AAPM 2018(American Association of Physicists in Medicine 60th annual meeting & exhibition), 2018/07/29, Without Invitation, English, American Association of Physicists in Medicine, Nashville TN, America
  66. Predictive gamma passing rate based on dose uncertainty for head-and-neck and prostate IMRT., Shiba E, Saito A, Tsuneda M, Furumi M, Yahara K, Ohguri T, Murakami Y, Nishio T, Korogi Y, Nagata Y., AAPM 2018(American Association of Physicists in Medicine 60th annual meeting & exhibition), 2018/07/29, Without Invitation, English, American Association of Physicists in Medicine, Nashville TN, America
  67. Dose calculation grid for 3D dose verification of VMAT using rotating 2D array of finite-size detectors., Saito A, Nakashima T, Okumura T, Aita M, Hioki K, Kawahara D, Masuda M, Miki K, Mori M, Naito K, Ochi Y, Tsubouchi T, Ohno Y, Nagata Y., AAPM 2018(American Association of Physicists in Medicine 60th annual meeting & exhibition), 2018/07/29, Without Invitation, English, American Association of Physicists in Medicine, Nashville TN, America
  68. Development of geometrically ideal dose distribution as a reference of treatment planning in VMAT with filtered back projection method., Miki K, Hioki K, Nakashima T, Saito A, Nagata Y., AAPM 2018(American Association of Physicists in Medicine 60th annual meeting & exhibition), 2018/07/29, Without Invitation, English, American Association of Physicists in Medicine, Nashville TN, America
  69. Automatic contrast medium extraction system using monochromatic CT number., Kawahara D, Ozawa S, Tanaka S, Yokomachi K, Saito A, Higaki T, Fujioka C, Tsuneda M, Mori M, Ohno Y, Nagata Y., AAPM 2018(American Association of Physicists in Medicine 60th annual meeting & exhibition), 2018/07/29, Without Invitation, English, American Association of Physicists in Medicine, Nashville TN, America
  70. Current status of SBRT in Japan., Nagata Y., Global Academic Programs 2018 (GAP), 2018/05/15, Without Invitation, English, Global Academic Programs, Stockholm, Sweden
  71. Accuracy of the Effective Atomic Numbers and Theoretical Monochromatic CT Numbers for Contrast Medium with Raw-data Based Dual-energy CT, Kawahara D,Ozawa S,Tanaka S,Yokomachi K,Fujioka C,Ohno Y,Nagata Y, 2018/04/12, Without Invitation, Japanese, Yokohama, Japan
  72. Clinical Value of Squamous Cell Carcinoma Antigen in Patients with Advanced Cervical Carcinoma Treated by Chemoradiotherapy, Wadasaki K,Nishibuchi I,Imano N,Nagata Y., The 77th Annual Meeting of the Japan Radiological Society, 2018/04/12, Without Invitation, Japanese, Japan Radiological Society
  73. Demand and Supply of Radiation Oncologists in Future., Nagata Y., The 77th Annual Meeting of the Japan Radiological Society, 2018/04/12, Without Invitation, Japanese, the Japan Radiological Society
  74. Simulation study of volumetric modulated arc therapy for thoracic esophageal cancer using automated-radiotherapy planning software., Murakami Y,Nagata Y,Kimura T,Nishibuchi I,Nakashima T, 2018 Gastorointestinal Cancers Symposium, 2018/01/18, Without Invitation, English, San Francisco(USA)
  75. Simulation study of volumetric modulated arc therapy for thoracic esophageal cancer using automated-radiotherapy planning software., Murakami Y,Nagata Y,Kimura T,Nishibuchi I,Nakashima T, 2018 Gastorointestinal Cancers Symposium, 2018/01/18, Without Invitation, English, San Francisco, USA
  76. Published clinical trials in Japan, JCOG0403, Nagata Y, 2017 Trilateral Symposium, 2017/12/09, With Invitation, English, Shenzhen, China.
  77. Ongoing clinical trials in Japan, JCOG1408, Nagata Y, 2017 Trilateral Symposium, 2017/12/09, Without Invitation, English, Shenzhen, China.
  78. Current status of stereotactic body radiation therapy (SBRT) in Japan., Yasushi Nagata, IASLC 17th World Conference on Lung Cancer, 2016/12/04, Without Invitation, English, IASLC, Vienna, Austria
  79. Impact of inflammation and sarcopenia on outcomes after stereotactic body radiotherapy for T1N0M0 non-small cell lung cancer., Matsuo Y, Nagata Y, Wakabayashi M, Eba J, Ishikura S, Onishi H, Kokubo M, Karasawa K, Shioyama Y, Onimaru R, Hiraoka M., IASLC 17th World Conference on Lung Cancer, 2016/12/04, Without Invitation, English, IASLC, Vienna, Austria
  80. Treatment results of definitive chemo-radiation therapy in patients with cervical esophageal cancer., Y. Takeuchi, Y. Murakami, I. Takahashi, I. Nishibuchi, T. Kimura, A. Saito, T. Nishio, Y. Nagata., 2016/11/25, Without Invitation, Japanese
  81. The use of diagnostic imging on Liver Cancer., Yaushi Nagata, 34th Annual Meeting of Korean Society for Radiation Oncology, 2016/10/14, With Invitation, English, Korean Society for Radiation Oncology, Seoul Korea
  82. Combined ventilationand perfusion imaging correlates with the dosimetric parameters of radiatoin pneumonitis in radiation therapy planning for lung cancer., T. Kimura, T. Nakashima, A. Saito, Y. Takeuchi, I. Takahashi, I. Nishibuchi, Y. Murakami, T. Nishio, Y. Nagata., Proceedings of the American Society for Radiation Oncology 57th annual meeting(ASTRO), 2016/09/25, Without Invitation, English, American Society for Radiation Oncology, Boston, MA, USA
  83. A simplified Three-Isocenter IMRT for craniospinal irradiation to minimize planning and treatment time, I. Takahashi, K. Kashiwado, Y. Takeuchi, I. Nishibuchi, A. Saito, T. Kimura, Y. Murakami, Y. Nagata, Proceedings of the American Society for Radiation Oncology 57th annual meeting(ASTRO), 2016/09/25, Without Invitation, English, American Society for Radiation Oncology, Boston, MA, USA
  84. Verification of mechanical and dosimetric accuracy for head and neck volumetric modulated arc therapy with jaw tracking, T. Okumura, T. Nakashima, M. Aita, Y. Ochi, D. Kawahara, H. Masuda, K. Hioki, Y. Ohno, A. Saito, Y. Nagata, Proceedings of the American Society for Radiation Oncology 57th annual meeting(ASTRO), 2016/09/25, Without Invitation, English, American Society for Radiation Oncology, Boston, MA, USA
  85. Salvage radiotherapy for superficial esophageal cancer after incomplete endoscopic resection, I. Nishibuchi, Y. Murakami, I. Takahashi, Y. Takeuchi, A. Saito, T. Kimura, T. Nishio, Y. Nagata, Proceedings of the American Society for Radiation Oncology 57th annual meeting(ASTRO), 2016/09/25, Without Invitation, English, American Society for Radiation Oncology, Boston, MA, USA
  86. Impact of expiratory tumor motion patterns on dose volume histogram in treatment phase selection of respiratory gating radiation therapy for lung cancer, N. Imano, I. Nishibuchi, T. Kimura, T. Nakashima, T. Okumura, Y. Murakami, Y. Nagata, Proceedings of the American Society for Radiation Oncology 57th annual meeting(ASTRO), 2016/09/25, Without Invitation, English, American Society for Radiation Oncology, Boston, MA, USA
  87. Analysis of DEF and energy spectrum with PHITS on Lipiodol using the flattened and unflattened photon beams., 2016/09/08, Without Invitation, Japanese
  88. Kompeito-Shot: Development of a Novel Verification System for 3D Beam Alignment Including the Sag of Gantry Head, M Tsuneda, T Nishio , A Saito, K Hioki , D Kawahara, Y Ochi, K Matsushita, S Tanaka, S Ozawa, Y Nagata, AAPM2016(the American Association of Physicists in Medicine), 2016/07/31, Without Invitation, English, the American Association of Physicists in Medicine, Washington, USA
  89. Energy Spectral Study On Lipiodol After Trans-Arterial Chemoembolization Using the Flattened and Unflattened Photon Beams, D Kawahara, S Ozawa, A Saito, T Nishio, K Hioki , H Masuda , T Okumura , Y Ochi , T Nakashima , T Suzuki, S Tanaka,Y Ohno, Y Nagata, AAPM2016(the American Association of Physicists in Medicine), 2016/07/31, Without Invitation, English, the American Association of Physicists in Medicine, Washington, USA
  90. Current Status of Stereotactic Body Radiation Therapy (SBRT) in Japan, Nagata Yasushi, GAP (Global Academic Program) related Meeting between Hiroshima University and The University of Texas MD Anderson Cancer Center, 2016/07/22, With Invitation, English, Hiroshima University and The University of Texas MD Anderson Cancer Center, Hiroshima city
  91. Stereotactic body radiotherapy for patients with small hepatocellular carcinoma ineligible for ablation therapies., T. Kimura, H. Aikata, I. Takahashi, Y. Takeuchi, I. Nishibuchi, Y. Murakami, K. Awai, K. Chayama, Y. Nagata, GAP (Global Academic Program) related Meeting between Hiroshima University and The University of Texas MD Anderson Cancer Center, 2016/07/22, Without Invitation, English, Hiroshima University and The University of Texas MD Anderson Cancer Center, Hiroshima city
  92. Evaluation of adverse events in Atomic Bomb survivors receiving curative-intent radiation therapy from 2005 to 2010, Y. Doi, Y. Murakami, M. Kenjo, T. Kimura, Y. Nagata, GAP (Global Academic Program) related Meeting between Hiroshima University and The University of Texas MD Anderson Cancer Center, 2016/07/22, Without Invitation, English, Hiroshima University and The University of Texas MD Anderson Cancer Center, Hiroshima Japan
  93. Clinical features of metachronous cancer in patients with esophageal cancer treated by definitive radiation therapy, Y. Murakami, Y. Takeuchi, I. Takahashi, I. Nishibuchi, T. Kimura, Y. Nagata, GAP (Global Academic Program) related Meeting between Hiroshima University and The University of Texas MD Anderson Cancer Center, 2016/07/22, Without Invitation, English, Hiroshima University and The University of Texas MD Anderson Cancer Center, Hiroshima Japan
  94. Dosimetric comparison between volumetric modulated arc therapy and conventional 3D conformal radiotherapy for middle thoracic esophageal cancer., Doi Y, Murakami Y., Kawabata H., Takeuchi Y., Nishibuchi I.,Okabe T., Kenjo M., Kimura T., Nagata Y., 2015/11/19, Without Invitation, English
  95. Gd-EOB-DTPA enhanced MRI guided stereotactic body radiation therapy planning for patients with hepatocellular carcinoma., Tsegmed U, Kimura T, Nakashima T, Nakamura Y, Higaki T, Imano N, Doi Y, Kenjo M, Ozawa S, Murakami Y, Awai K, Nagata Y., Proceedings of the American Society for Radiation Oncology 57th annual meeting(ASTRO), 2015/10/18, Without Invitation, English, American Society for Radiation Oncology, San Antonio,Texas, USA
  96. Current status of Stereotatic Body Radiation Therapy (SBRT) in Japan., Yasushi Nagata, 15th International Congress of Radiation Research, 2015/05/25, Without Invitation, English, International Congress of Radiation Research, Kyoto, Japan
  97. Evaluation of Beam Modeling for Small Field using Flattening Filter Free, Daisuke Kawahara, The 15th International congress of Radiation Research(ICRR), 2015/05/25, Without Invitation, English, International congress of Radiation Research, Kyoto, Japan
  98. Stereotactic body radiotherapy for early stage lung cancer., Yasushi Nagata, The 3rd International Medical Symposium of Dong-A University., 2014/02/07, With Invitation, English, Dong-A University., Busan, Korea.
  99. SBRT for lung cancer in Japan, Yasushi Nagata, HICARE/IAEA International Training Course. 2015.1.19-22. Hiroshima., With Invitation, English, HICARE, Hiroshima, Japan

Awards

  1. 2021/10/03, The 5th Meeting of the Federation of Asian Organizations for Radiation Oncology(FARO) Best proffered paper presentation, Third place, The Federation of Asian Organizations for Radiation Oncology(FARO)(President), Sub-region based radiomic analysis for pretreatment prediction of recurrence after radiotherapy in locally advanced cervical cancer.
  2. 2021/10/03, The 5th Meeting of the Federation of Asian Organizations for Radiation Oncology(FARO) Best proffered paper presentation, Third place, The Federation of Asian Organizations for Radiation Oncology(FARO)(President), Prediction of radiation pneumonitis after definitive radiotherapy for locally advanced non-small cell lung cancer using multi-region radiomics analysis.
  3. 2018/05/20, Honorary Fellowship, American College of Radiology

External Funds

Acceptance Results of Competitive Funds

  1. 2015, 2015
  2. Practical Research for Innovative Cancer Control , 2017/04/01, 2018/03/31
  3. Practical Research for Innovative Cancer Control , 2018/04/01, 2019/03/31
  4. Practical Research for Innovative Cancer Control , 2019/04/01, 2020/03/31

Social Activities

Organizing Academic Conferences, etc.

  1. 2021/07, 2021/07
  2. 2022/03, 2022/03
  3. 2021/04, 2021/04
  4. 2019/05, 2019/05
  5. 2019/11, 2019/11
  6. 2019/10, 2019/10
  7. 2019/11, 2019/11
  8. 2020/02, 2020/02
  9. 2012/07
  10. 2012/07
  11. 2016/06, 2016/06
  12. 2015/08, 2015/08
  13. 2018/08, 2018/08